These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dialysis encephalopathy. Alfrey AC Kidney Int Suppl; 1986 Feb; 18():S53-7. PubMed ID: 3457997 [No Abstract] [Full Text] [Related]
4. [Water purification in dialysis treatment. Aluminum and encephalopathy]. Hagstam KE; Lindergård B; Lindholm T; Thysell H Lakartidningen; 1980 Jun; 77(26-27):2425-7. PubMed ID: 7401791 [No Abstract] [Full Text] [Related]
5. Dialysis encephalopathy associated with polyvalent ion contamination. Hocken AG N Z Med J; 1984 Mar; 97(752):190-2. PubMed ID: 6583579 [TBL] [Abstract][Full Text] [Related]
6. The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy. Milne FJ; Sharf B; Bell P; Meyers AM Clin Nephrol; 1983 Oct; 20(4):202-7. PubMed ID: 6641027 [TBL] [Abstract][Full Text] [Related]
7. Role of desferrioxamine in the treatment of dialysis encephalopathy. Ackrill P; Ralston AJ; Day JP Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985 [No Abstract] [Full Text] [Related]
19. Dialysis dementia: the role of dialysate pH in altering the dialyzability of aluminum. Gacek EM; Babb AL; Uvelli DA; Fry DL; Scribner BH Trans Am Soc Artif Intern Organs; 1979; 25():409-15. PubMed ID: 43004 [No Abstract] [Full Text] [Related]